In addition, as PAH mediates the conversion of phenylalanine (Phe) to tyrosine (Tyr), hyperphenylalaninemia (HPA) is present in all BH 4 deficiencies apart from autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (AD-GTPCHD) and sepiapterin reductase deficiency (SRD) [1, 2]
Semaglutide and Tirzepatide break the cycle by: Improving insulin sensitivity directly addressing the metabolic dysfunction at the core of PMOS Promoting meaningful fat loss particularly visceral fat, which is the most metabolically active and most closely linked to insulin resistance and androgen production Reducing appetite and cravings addressing the carbohydrate cravings that insulin resistance drives, making dietary changes sustainable rather than torturous Lowering androgen levels indirectly as insulin improves and visceral fat decreases, androgen production often normalizes, improving acne, hair loss, and menstrual regularity without additional medications Reducing cardiovascular risk GLP-1 agonists have demonstrated cardioprotective effects, which is significant given the elevated cardiovascular risk PMOS carries At Refine by Tulsi, our medical weight loss program combines GLP-1 therapy with peptide protocols, nutritional guidance, exercise planning, and monthly weigh-ins ensuring that weight loss preserves lean muscle and addresses the metabolic dysfunction rather than just the number on the scale
By facilitating the removal of protein aggregates, paeoniflorin may reduce one source of toxicity in PD
FIGURE 3 8.7 The role of ferroptosis in atherosclerosis with depression Ferroptosis influences the onset of AS and depression through inflammation, mitochondrial dysfunction, and gut microbiota, respectively
By engineering a patients T-cells to specifically recognize senescence-associated surface antigens, CAR-T therapy achieves highly precise targeting of SnCs
